chrX-9759416-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_000273.3(GPR143):c.371A>G(p.Gln124Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000353 in 1,177,095 control chromosomes in the GnomAD database, including 1 homozygotes. There are 121 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00027 ( 0 hom., 7 hem., cov: 23)
Exomes 𝑓: 0.00036 ( 1 hom. 114 hem. )
Consequence
GPR143
NM_000273.3 missense
NM_000273.3 missense
Scores
6
9
2
Clinical Significance
Conservation
PhyloP100: 6.88
Publications
3 publications found
Genes affected
GPR143 (HGNC:20145): (G protein-coupled receptor 143) This gene encodes a protein that binds to heterotrimeric G proteins and is targeted to melanosomes in pigment cells. This protein is thought to be involved in intracellular signal transduction mechanisms. Mutations in this gene cause ocular albinism type 1, also referred to as Nettleship-Falls type ocular albinism, a severe visual disorder. A related pseudogene has been identified on chromosome Y. [provided by RefSeq, Dec 2009]
GPR143 Gene-Disease associations (from GenCC):
- inherited retinal dystrophyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- ocular albinismInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- nystagmus 6, congenital, X-linkedInheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- X-linked recessive ocular albinismInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 12 uncertain in NM_000273.3
BP4
Computational evidence support a benign effect (MetaRNN=0.04116428).
BP6
Variant X-9759416-T-C is Benign according to our data. Variant chrX-9759416-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 98632.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000269 (30/111560) while in subpopulation AMR AF = 0.000578 (6/10372). AF 95% confidence interval is 0.000251. There are 0 homozygotes in GnomAd4. There are 7 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 7 XL gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GPR143 | NM_000273.3 | c.371A>G | p.Gln124Arg | missense_variant | Exon 3 of 9 | ENST00000467482.6 | NP_000264.2 | |
| GPR143 | NM_001440781.1 | c.371A>G | p.Gln124Arg | missense_variant | Exon 3 of 9 | NP_001427710.1 | ||
| GPR143 | XM_024452388.2 | c.119A>G | p.Gln40Arg | missense_variant | Exon 3 of 9 | XP_024308156.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GPR143 | ENST00000467482.6 | c.371A>G | p.Gln124Arg | missense_variant | Exon 3 of 9 | 1 | NM_000273.3 | ENSP00000417161.1 | ||
| GPR143 | ENST00000447366.5 | c.119A>G | p.Gln40Arg | missense_variant | Exon 3 of 8 | 3 | ENSP00000390546.2 | |||
| GPR143 | ENST00000431126.1 | c.119A>G | p.Gln40Arg | missense_variant | Exon 3 of 6 | 3 | ENSP00000406138.1 | |||
| GPR143 | ENST00000480178.1 | n.-22A>G | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 30AN: 111560Hom.: 0 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
30
AN:
111560
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000519 AC: 85AN: 163845 AF XY: 0.000343 show subpopulations
GnomAD2 exomes
AF:
AC:
85
AN:
163845
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000361 AC: 385AN: 1065535Hom.: 1 Cov.: 26 AF XY: 0.000341 AC XY: 114AN XY: 334509 show subpopulations
GnomAD4 exome
AF:
AC:
385
AN:
1065535
Hom.:
Cov.:
26
AF XY:
AC XY:
114
AN XY:
334509
show subpopulations
African (AFR)
AF:
AC:
0
AN:
25667
American (AMR)
AF:
AC:
61
AN:
34228
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19073
East Asian (EAS)
AF:
AC:
0
AN:
29643
South Asian (SAS)
AF:
AC:
0
AN:
51824
European-Finnish (FIN)
AF:
AC:
0
AN:
39956
Middle Eastern (MID)
AF:
AC:
0
AN:
4052
European-Non Finnish (NFE)
AF:
AC:
315
AN:
816063
Other (OTH)
AF:
AC:
9
AN:
45029
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000269 AC: 30AN: 111560Hom.: 0 Cov.: 23 AF XY: 0.000207 AC XY: 7AN XY: 33748 show subpopulations
GnomAD4 genome
AF:
AC:
30
AN:
111560
Hom.:
Cov.:
23
AF XY:
AC XY:
7
AN XY:
33748
show subpopulations
African (AFR)
AF:
AC:
5
AN:
30656
American (AMR)
AF:
AC:
6
AN:
10372
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2654
East Asian (EAS)
AF:
AC:
0
AN:
3570
South Asian (SAS)
AF:
AC:
0
AN:
2652
European-Finnish (FIN)
AF:
AC:
0
AN:
6066
Middle Eastern (MID)
AF:
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
AC:
19
AN:
53167
Other (OTH)
AF:
AC:
0
AN:
1507
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
58
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Jul 28, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 17, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1Other:1
-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
Dec 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ocular albinism, type I Benign:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;D
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;.;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D
REVEL
Pathogenic
Sift
Uncertain
D;.;D
Sift4G
Uncertain
D;D;.
Polyphen
P;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.